Home » Pay at the Start for Type IA Variation Reviews, EMA Declares
Pay at the Start for Type IA Variation Reviews, EMA Declares
December 9, 2011
As of Jan. 1, holders of European Medicines Agency (EMA) marketing authorizations for human and veterinary medicines must pay fees for type 1A variation reviews at the start of the 30-day process, the EMA says.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor